LMO3 and neuroblastoma: In this regard, it is interesting that aberrantly high LMO3 expression levels appear to be frequent in neuroblastomas with MYCN gene amplification (Figure 6I), which may explain the lack of association of the rs2168101 genotype with the risk of developing MYCN-amplified neuroblastomas (20).